| Date Filed | Type | Description |
| 06/16/2023 |
4
| Smith Robin L (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
3
| Smith Robin L (Director) has filed a Form 3 on Western Acquisition Ventures Corp. |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Smith Robin L (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Exercised 75,000 options
@ $3.95, valued at
$296.3k
Exercised 100,000 options
@ $4.89, valued at
$489k
|
|
| 08/30/2021 |
4
| Smith Robin L (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $8.86, valued at
$2.2M
|
|
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $4.89, valued at
$489k
|
|
| 05/21/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on SERVICESOURCE INTERNATIONAL, INC.|
Txns:
| Bought 50,000 shares
@ $1.7, valued at
$85k
|
|
| 05/14/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on SERVICESOURCE INTERNATIONAL, INC.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/06/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on SERVICESOURCE INTERNATIONAL, INC.|
Txns:
| Granted 17,975 shares
@ $0 |
|
| 03/06/2020 |
3
| Smith Robin L (Director) has filed a Form 3 on SERVICESOURCE INTERNATIONAL, INC. |
| 03/05/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Bought 40,000 shares
@ $2.2724, valued at
$90.9k
|
|
| 01/07/2020 |
4
| Smith Robin L (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 16,000 options to buy
@ $1.42, valued at
$22.7k
|
|
| 12/18/2019 |
4
| Smith Robin L (Director) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 75,000 options
@ $3.95, valued at
$296.3k
|
|
| 12/18/2019 |
3
| Smith Robin L (Director) has filed a Form 3 on Sorrento Therapeutics, Inc. |
| 06/10/2019 |
4
| Smith Robin L (Director) has filed a Form 4 on ROCKWELL MEDICAL, INC.|
Txns:
| Granted 21,566 shares
@ $0
Granted 22,461 options to buy
@ $4.15, valued at
$93.2k
|
|
| 05/10/2019 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 50,000 shares
@ $1.19, valued at
$59.5k
Granted 100,000 options to buy
@ $1.19, valued at
$119k
|
|
| 03/21/2019 |
4
| Smith Robin L (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $2.33, valued at
$55.9k
Granted 16,000 options to buy
@ $2.33, valued at
$37.3k
|
|
| 01/28/2019 |
3
| Smith Robin L (Director) has filed a Form 3 on SEELOS THERAPEUTICS, INC. |
| 11/30/2018 |
SC 13D
| Smith Robin L reports a 6.5% stake in MYnd Analytics, Inc. |
| 10/10/2018 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 48,000 options to buy
@ $1.38, valued at
$66.2k
|
|
| 09/25/2018 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 13,513 shares
@ $1.85, valued at
$25k
Granted 13,513 warrants
@ $2, valued at
$27k
|
|
| 05/14/2018 |
4
| Smith Robin L (Director) has filed a Form 4 on PROLUNG INC|
Txns:
| Granted 7,320 options to buy
@ $8, valued at
$58.6k
|
|
| 04/24/2018 |
4/A
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
Granted 50,000 options to buy
@ $1.99, valued at
$99.5k
|
|
| 04/20/2018 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
Granted 150,000 options to buy
@ $1.99, valued at
$298.5k
|
|
| 03/21/2018 |
4
| Smith Robin L (Director) has filed a Form 4 on ROCKWELL MEDICAL, INC.|
Txns:
| Granted 38,985 options to buy
@ $5.75, valued at
$224.2k
|
|
| 11/20/2017 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 08/30/2017 |
4
| Smith Robin L (Director) has filed a Form 4 on PROLUNG INC|
Txns:
| Granted 20,000 options to buy
@ $1, valued at
$20k
Granted 30,000 options to buy
@ $1, valued at
$30k
Granted 70,000 options to buy
@ $1.25, valued at
$87.5k
|
|
| 08/23/2017 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $4.33, valued at
$324.8k
Granted 50,000 options to buy
@ $4.16, valued at
$208k
|
|
| 08/10/2017 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $6, valued at
$48k
|
|
| 07/18/2017 |
4
| Smith Robin L (Director) has filed a Form 4 on MYnd Analytics, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 8,000 options to buy
@ $6, valued at
$48k
Granted 8,000 options to buy
@ $6, valued at
$48k
|
|
|